Deisy Segura-Villalobos obtained a master’s degree in Neuropharmacology and Experimental Therapeutics at the Center for Research and Advanced Studies (Cinvestav). Currently, she is going through the senior year of her Ph.D. at Cinvestav, and her doctoral research project focuses on the description of phenotypic changes induced by cyclic hypoxia in mast cells. She is particularly interested in understanding how different stimuli modify the mast cell phenotype and how this influences cancer progression. She has analyzed transcriptomic data from mast cells subjected to cyclic hypoxia and has found changes related to the FcεRI signaling pathway triggered by that condition.